Six months of OCP treatment significantly increased serum ICAM-1, MCP-1 and TNF- α levels in women with PCOS [22], but no significant difference was observed in plasma PAI-1 levels [23]. The gene discussed is CCL2; the disease is polycystic ovary syndrome.